March 07, 2025

Early Excellence in Science Award for Ivana Winkler

Early Excellence in Science Award for Ivana Winkler

The Bayer Foundation’s Early Excellence in Science Award 2024 in the category of Data Science goes to Ivana Winkler of the German Cancer Research Center (DKFZ). Winkler’s work uncovered the unexpected effect of female reproductive capacity: the constantly recurring remodeling of the organs of the female reproductive tract during the sexual cycle leads to fibrosis and chronic inflammation over the years.

Source: Bayer Foundation

The organs of the female reproductive tract undergo extensive remodeling during each monthly cycle in preparation for ovulation or pregnancy. The effects of this recurring remodeling on the affected organs, including the ovaries, fallopian tubes, uterus, cervix, and vagina, have not yet been sufficiently researched. Much of the work that has been done so far has been based on purely microscopic examinations or has only looked at individual organs or the activity of certain genes.

Ivana Winker, a postdoc in the Molecular and Computational Prevention Division at the DKFZ, has systematically examined the changes in gene activity and morphology in mice in all affected organs during each phase of the cycle – at the level of individual cells and in spatial resolution. This enabled her and her colleagues to compile a cell atlas of the female reproductive tract.

Many physiological reproductive events, such as ovulation, menstruation or implantation of the fertilized egg, show characteristic signs of inflammation. The molecular signaling pathways and molecules that maintain this inflammation largely originate from connective tissue cells, one of the main sources of pro-inflammatory messengers.

A remarkable feature of the female reproductive tract is its ability to rapidly clear these cyclically occurring inflammations and restore normal reproductive function. Inflammation that does not resolve, coupled with other signs of aging, can become chronic and lead to fibrosis.

Based on their results, Winkler and colleagues developed a model in which repeated remodeling of the reproductive tract over the reproductive lifespan drives a gradual, age-related development of fibrosis and chronic inflammation. They were able to test this hypothesis directly by using drugs to block the estrous cycle. This cycle blockade reduced progressive fibrosis, while other aging processes continued to proceed normally.

The atlas highlights how the interplay of estrus cycling, pregnancy, and aging sculpts the female reproductive tract. For a long time, it was assumed that these events left no traces or scars in the affected organs. The work of Winkler and colleagues reveals the unexpected price of female reproductive capacity, which is paid for by the constant remodeling of the female reproductive tract. Although these results have so far only been observed in mice, they have great potential for, among other things, developing new therapies to combat cancer in the reproductive organs of women.

The Bayer Foundation grants the Early Excellence in Science Awards, which are endowed with 10,000 euros each, annually to outstanding young scientists and physicians at the beginning of their academic and clinical research careers. The award is given in four categories: biology, chemistry, medicine and data science.

Our latest News

discover more
The Heidelberg and Mannheim University Hospitals consortium has taken first place in the Stern hospital rankings

The Heidelberg and Mannheim University Hospitals consortium has taken first place in the Stern hospital rankings

For the first time in 14 years, there has been a change at the top of the hospital rankings, which are published annually by the MINQ Institute in collaboration with Stern. In its very first year of existence, the Heidelberg and Mannheim University Hospitals Consortium has taken first place. More information in German below: Zusammen […]

Presentation of the EY German Biotechnology Report 2026 in Heidelberg: Strong Innovation Ecosystems Are Key to Scaling Innovation

Presentation of the EY German Biotechnology Report 2026 in Heidelberg: Strong Innovation Ecosystems Are Key to Scaling Innovation

Heidelberg, 11 June 2026 – Germany continues to produce world-class science, breakthrough technologies and highly innovative biotechnology companies. However, the challenge is no longer generating innovation – it is creating the conditions that allow innovation to scale. This was one of the central messages emerging from the presentation of the EY German Biotechnology Report 2026, […]

CELASC 2026 presentation: Impact of topical lidocaine-prilocaine analgesia on pain-induced grooming after ear notching of mice

CELASC 2026 presentation: Impact of topical lidocaine-prilocaine analgesia on pain-induced grooming after ear notching of mice

Finnish animal welfare legislation (Government Decree 1165/2023) effective as of January 1, 2024, requires establishments to apply “appropriate pain relief” in association with ear notching identification method of laboratory rodents(1). However, there is a lack of scientific evidence whether the benefits of applying analgesia outweigh the additional stress related to handling and drug administration. Our […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp